Skip to main content
Clinical Trials/CTRI/2023/07/055698
CTRI/2023/07/055698
Not Yet Recruiting
N/A

The objective of the study is to evaluate the efficacy and safety of a skin care formulation in terms of reduction in dark spots (Acne Post Inflammatory Hyperpigmentation), moisturisation, even skin tone & softness of skin, visible reduction in appearance of pore, reduction in closed and open comedos and Sebum content (oil reduction) on healthy female subjects. - NI

Transformative Learning Solution Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Transformative Learning Solution Pvt Ltd
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Transformative Learning Solution Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\)Indian / Asian female subjects.
  • 2\) Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup).
  • 3\)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.).
  • 4\)For group A:Having darkspots (acne Post Inflammatory Hyperpigmentation) on face, Having uneven skin tone.
  • 5\)For group B:Having mixed oily or oily skin type , with visible pore.Having open, closed comedons.

Exclusion Criteria

  • 1\)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
  • 2\)Having refused to give her assent by signing the consent form.
  • 3\)Taking part in another study liable to interfere with this study.
  • 4\)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
  • 5\)Being insulin\-dependent diabetic or non\-insulin\-dependent diabetic with a recent therapy (less than 6 months).
  • 6\)Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • 7\)Being epileptic.
  • 8\)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months).
  • 9\)Having cutaneous hypersensitivity.
  • 10\)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex.

Outcomes

Primary Outcomes

Not specified

Similar Trials